Off-the-Shelf CAR-NK cells engineered to express calibrated release IL-15 exhibit enhanced persistence and anti-tumor activities

被引：0
|
作者：
Lee, Chen-Ting
Hung, Michelle
Banicki, Andrew
Song, Wenqi
Almudhfar, Niran
Kaveri, Deepika
Wong, Priscilla
Naitmazi, Lawrence
Guzman, Marcela
Lam, Alice
Yucel, Gozde
Lu, Timothy
Junca, Alba G.
Garrison, Brian
Lee, Philip
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2902
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Co-expression of membrane bound IL-15 enhanced anti-tumor response of CAR-T
    Yang, Cuiqing
    Jiang, Fuwei
    Wang, Yifang
    Liu, Tingting
    Wang, Chao
    Wang, Qingyang
    Wang, Qin
    Ye, Gang
    Tang, Renhong
    Cao, Zhuoxiao
    CANCER RESEARCH, 2023, 83 (07)
  • [22] An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma
    Ma, Rui
    Lu, Ting
    Li, Zhenlong
    Teng, Kun-Yu
    Mansour, Anthony G.
    Yu, Melissa
    Tian, Lei
    Xu, Bo
    Ma, Shoubao
    Zhang, Jianying
    Barr, Tasha
    Peng, Yong
    Caligiuri, Michael A.
    Yu, Jianhua
    CANCER RESEARCH, 2021, 81 (13) : 3635 - 3648
  • [23] Fourth generation Glypican-3-specific CAR-NK cells co-secreting IL-15 and IFN-α have increased anti-tumor function versus hepatocellular carcinoma
    Badami, Ester
    Busa, Rosalia
    Gallina, Anna
    Iannolo, Gioacchin
    Amico, Giandomenico
    Douradinha, Bruno
    Conaldi, Pier Giulio
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [24] Anti-hPSMA CAR engineered NK-92 cells: An Off-The-Shelf cellular therapeutic for targeted elimination of prostate cancer cells
    Zuccolotto, G.
    Rosato, A.
    EUROPEAN JOURNAL OF CANCER, 2019, 110 : S26 - S27
  • [25] ANTI-HPSMA CAR ENGINEERED NK-92 CELLS: AN OFF-THE-SHELF CELLULAR THERAPEUTIC FOR TARGETED ELIMINATION OF PROSTATE CANCER CELLS
    Zuccolotto, G.
    Penna, A.
    Montagner, I. M.
    Carpanese, D.
    Rosato, A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A45 - A45
  • [26] IL-15 has innate anti-tumor activity independent of NK and CD8 T cells
    Davies, Elizabeth
    Reid, Sarah
    Medina, Maria Fe
    Lichty, Brian
    Ashkar, Ali A.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (03) : 529 - 536
  • [27] FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies
    Goodridge, Jode P.
    Mahmood, Sajid
    Zhu, Huang
    Gaidarova, Svetlana
    Blum, Robert
    Bjordahl, Ryan
    Cichocki, Frank
    Chu, Hui-yi
    Bonello, Greg
    Lee, Tom
    Groff, Brian
    Meza, Miguel
    Walcheck, Bruce
    Malmberg, Karl-Johan
    Miller, Jeffrey S.
    Kaufman, Dan S.
    Valamehr, Bahram
    BLOOD, 2019, 134
  • [28] Glypican-3-Specific CAR NKT Cells Armored with IL-15 Exhibit Potent and Sustained Anti-Tumor Activity against Hepatocellular Carcinoma
    Thao Nguyen
    Rathi, Purva
    Batra, Sai
    Courtney, Amy
    Metelitsa, Leonid
    Heczey, Andras
    MOLECULAR THERAPY, 2018, 26 (05) : 62 - 62
  • [29] FT516, an off-the-shelf engineered NK cell therapeutic product for universal anti-tumor targeting strategy in combination with monoclonal antibodies
    Bjordahl, Ryan
    Zhu, Huang
    Rogers, Paul
    Gaidarova, Svetlana
    Ge, Moyar Q.
    Blum, Robert
    Cichocki, Frank
    Goodridge, Jode
    Chu, Helen
    Bonello, Greg
    Lee, Tom
    Groff, Brian
    Abujarour, Ramzey
    Walcheck, Bruce
    Miller, Jeffrey
    Kaufman, Dan
    Valamehr, Bahram
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Enhanced anti-tumor efficacy of "IL-15 and CCL19" -secreting CAR-T cells in human glioblastoma orthotopic xenograft model
    Chen, Wanqiong
    Hong, Limian
    Lin, Shaomei
    Xian, Na
    Yan, Cailing
    Zhao, Ningning
    Xiao, Yonglei
    Liao, Wanting
    Huang, Yuxiang
    Chen, Mingzhu
    FRONTIERS IN ONCOLOGY, 2025, 15
12345